Acquired and genetic complement abnormalities play a critical role in dense deposit disease and other C3 glomerulopathies

Appel, 2005, Membranoproliferative glomerulonephritis type II (dense deposit disease): an update, J Am Soc Nephrol, 16, 1392, 10.1681/ASN.2005010078 Servais, 2007, Primary glomerulonephritis with isolated C3 deposits: a new entity which shares common genetic risk factors with haemolytic uraemic syndrome, J Med Genet, 44, 193, 10.1136/jmg.2006.045328 Fakhouri, 2007, C3 glomerulopathy: a new classification, Nat Rev Nephrol, 6, 494, 10.1038/nrneph.2010.85 Walker, 2007, Dense deposit disease is not a membranoproliferative glomerulonephritis, Mod Pathol, 20, 605, 10.1038/modpathol.3800773 Sethi, 2009, Glomeruli of Dense Deposit Disease contain components of the alternative and terminal complement pathway, Kidney Int, 75, 952, 10.1038/ki.2008.657 Berger, 1974, Complement deposition in the kidney, vol 4, 37 Boyer, 2008, Complement factor H deficiency and posttransplantation glomerulonephritis with isolated C3 deposits, Am J Kidney Dis, 51, 671, 10.1053/j.ajkd.2007.11.032 Sethi, 2011, Proliferative glomerulonephritis secondary to dysfunction of the alternative pathway of complement, Clin J Am Soc Nephrol, 6, 1009, 10.2215/CJN.07110810 Servais, 2011, Heterogeneous pattern of renal disease associated with homozygous Factor H deficiency, Hum Pathol, 42, 1305, 10.1016/j.humpath.2010.11.023 Martinez-Barricarte, 2010, Human C3 mutation reveals a mechanism of dense deposit disease pathogenesis and provides insights into complement activation and regulation, J Clin Invest, 120, 3702, 10.1172/JCI43343 Licht, 2007, MPGN II--genetically determined by defective complement regulation?, Pediatr Nephrol, 22, 2, 10.1007/s00467-006-0299-8 Pickering, 2007, Spontaneous hemolytic uremic syndrome triggered by complement factor H lacking surface recognition domains, J Exp Med, 204, 1249, 10.1084/jem.20070301 Abrera-Abeleda, 2006, Variations in the complement regulatory genes factor H (CFH) and factor H related 5 (CFHR5) are associated with membranoproliferative glomerulonephritis type II (dense deposit disease), J Med Genet, 43, 582, 10.1136/jmg.2005.038315 Nasr, 2008, Dense deposit disease: clinicopathologic study of 32 pediatric and adult patients, Clin J Am Soc Nephrol, 4, 22, 10.2215/CJN.03480708 Bao, 2011, Complement factor H deficiency accelerates development of lupus nephritis, J Am Soc Nephrol, 22, 285, 10.1681/ASN.2010060647 Sellier-Leclerc, 2007, Differential impact of complement mutations on clinical characteristics in atypical hemolytic uremic syndrome, J Am Soc Nephrol, 18, 2392, 10.1681/ASN.2006080811 Fakhouri, 2010, Pregnancy-associated hemolytic uremic syndrome revisited in the era of complement gene mutations, J Am Soc Nephrol, 21, 859, 10.1681/ASN.2009070706 Wu, 2009, Structure of complement fragment C3b-factor H and implications for host protection by complement regulators, Nat Immunol, 10, 728, 10.1038/ni.1755 Noris, 2006, Complement factor h gene abnormalities in haemolytic uraemic syndrome: from point mutations to hybrid gene, PLoS Med, 3, e432, 10.1371/journal.pmed.0030432 Ferreira, 2009, The binding of factor H to a complex of physiological polyanions and C3b on cells is impaired in atypical hemolytic uremic syndrome, J Immunol, 182, 7009, 10.4049/jimmunol.0804031 Jokiranta, 2000, Each of the three binding sites on complement factor H interacts with a distinct site on C3b, J Biol Chem, 275, 27657, 10.1074/jbc.M002903200 Bienaime, 2010, Mutations in components of complement influence the outcome of Factor I-associated atypical hemolytic uremic syndrome, Kidney Int, 77, 339, 10.1038/ki.2009.472 Nilsson, 2010, Mutations in complement factor I as found in atypical hemolytic uremic syndrome lead to either altered secretion or altered function of factor I, Eur J Immunol, 40, 172, 10.1002/eji.200939280 Caprioli, 2006, Genetics of HUS: the impact of MCP, CFH and IF mutations on clinical presentation, response to treatment, and outcome, Blood, 108, 1267, 10.1182/blood-2005-10-007252 Nilsson, 2007, A mutation in factor I that is associated with atypical hemolytic uremic syndrome does not affect the function of factor I in complement regulation, Mol Immunol, 44, 1835, 10.1016/j.molimm.2006.10.005 Fang, 2008, Membrane cofactor protein mutations in atypical hemolytic uremic syndrome (aHUS), fatal Stx-HUS, C3 glomerulonephritis, and the HELLP syndrome, Blood, 111, 624, 10.1182/blood-2007-04-084533 Little, 2006, Severity of primary MPGN, rather than MPGN type, determines renal survival and post-transplantation recurrence risk, Kidney Int, 69, 504, 10.1038/sj.ki.5000084 Cameron, 1983, Idiopathic mesangiocapillary glomerulonephritis. Comparison of types I and II in children and adults and long-term prognosis, Am J Med, 74, 175, 10.1016/0002-9343(83)90606-X Swainson, 1983, Mesangiocapillary glomerulonephritis: a long-term study of 40 cases, J Pathol, 141, 449, 10.1002/path.1711410404 di Belgiojoso, 1977, The prognostic value of some clinical and histological parameters in membranoproliferative glomerulonephritis (MPGN): report of 112 cases, Nephron, 19, 250, 10.1159/000180897 Schwertz, 2001, Complement analysis in children with idiopathic membranoproliferative glomerulonephritis: a long-term follow-up, Pediatr Allergy Immunol, 12, 166, 10.1034/j.1399-3038.2001.012003166.x Vikse, 2002, Prognostic factors in mesangioproliferative glomerulonephritis, Nephrol Dial Transplant, 17, 1603, 10.1093/ndt/17.9.1603 Fischer, 1984, Protection of the classical and alternative complement pathway C3 convertases, stabilized by nephritic factors, from decay by the human C3b receptor, Eur J Immunol, 14, 1111, 10.1002/eji.1830141209 Schena, 1982, Biological significance of the C3 nephritic factor in membranoproliferative glomerulonephritis, Clin Nephrol, 18, 240 Hogasen, 1995, Hereditary porcine membranoproliferative glomerulonephritis type II is caused by factor H deficiency, J Clin Invest, 95, 1054, 10.1172/JCI117751 Pickering, 2002, Uncontrolled C3 activation causes membranoproliferative glomerulonephritis in mice deficient in complement factor H, Nat Genet, 31, 424, 10.1038/ng912 Saunders, 2007, The interactive Factor H-atypical hemolytic uremic syndrome mutation database and website: update and integration of membrane cofactor protein and Factor I mutations with structural models, Hum Mutat, 28, 222, 10.1002/humu.20435 Hageman, 2005, A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration, Proc Natl Acad Sci USA, 102, 7227, 10.1073/pnas.0501536102 Clark, 2006, His-384 allotypic variant of factor H associated with age-related macular degeneration has different heparin binding properties from the non-disease-associated form, J Biol Chem, 281, 24713, 10.1074/jbc.M605083200 Herbert, 2007, Structure shows that a glycosaminoglycan and protein recognition site in factor H is perturbed by age-related macular degeneration-linked single nucleotide polymorphism, J Biol Chem, 282, 18960, 10.1074/jbc.M609636200 Skerka, 2007, Defective complement control of factor H (Y402H) and FHL-1 in age-related macular degeneration, Mol Immunol, 44, 3398, 10.1016/j.molimm.2007.02.012 Rodriguez de Cordoba, 2011, Lessons from functional and structural analyses of disease-associated genetic variants in the complement alternative pathway, Biochim Biophys Acta, 1812, 12, 10.1016/j.bbadis.2010.09.002 Rose, 2008, Factor I is required for the development of membranoproliferative glomerulonephritis in factor H-deficient mice, J Clin Invest, 118, 608 Fremeaux-Bacchi, 2005, The development of atypical HUS is influenced by susceptibility factors in factor H and membrane cofactor protein- evidence from two independent cohorts, J Med Genet, 42, 852, 10.1136/jmg.2005.030783 Esparza-Gordillo, 2005, Predisposition to atypical hemolytic uremic syndrome involves the concurrence of different susceptibility alleles in the regulators of complement activation gene cluster in 1q32, Hum Mol Genet, 14, 703, 10.1093/hmg/ddi066 Roumenina, 2011, Alternative complement pathway assessment in patients with atypical HUS, J Immunol Methods, 365, 8, 10.1016/j.jim.2010.12.020 Fremeaux-Bacchi, 1994, Selective disappearance of C3NeF IgG autoantibody in the plasma of a patient with membranoproliferative glomerulonephritis following renal transplantation, Nephrol Dial Transplant, 9, 811 Levey, 2005, Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO), Kidney Int, 67, 2089, 10.1111/j.1523-1755.2005.00365.x Schwartz, 1984, A simple estimate of glomerular filtration rate in full-term infants during the first year of life, J Pediatr, 104, 849, 10.1016/S0022-3476(84)80479-5 Schwartz, 1985, A simple estimate of glomerular filtration rate in adolescent boys, J Pediatr, 106, 522, 10.1016/S0022-3476(85)80697-1 Schwartz, 1976, A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine, Pediatrics, 58, 259, 10.1542/peds.58.2.259